Skip to main content
  • Home
  • Platform
  • Science
  • Programs
  • Team
  • News
Contact
Menu
  • 01Home→
  • 02Platform→
  • 03Science→
  • 04Programs→
  • 05Team→
  • 06News→
  • 07Contact→
CB Therapeutics

Precision synthetic biology.
Carlsbad, CA.

Company

  • Team
  • News
  • Contact

Tech

  • Science
  • Platform

Programs

  • TryptageniX
  • TryptageniX AI
  • Aevora
  • Korvane

Contact

  • info@cbthera.com
  • +1 (833) 322-8437
CB Therapeutics
2463 Impala Drive
Carlsbad, CA 92010
© 2026 CB Therapeutics · All rights reservedA biological supply chain · For mental health.
Supply as platform

Supply‑chain program for rare chemistry.

TryptageniX develops fermentation routes for natural-product classes where access is limited by scarce, variable, or difficult source material.

Editorial botanical source image for MIA pathway.
Monoterpene indole alkaloids

MIA pathway

Voacanga africana and Catharanthus roseus run the same pathway. Trace yields, slow harvests, and structural complexity sit between every botanical source and a usable supply.

Run the pathway in yeast: secologanin to strictosidine, into stemmadenine acetate, then the tabersonine and catharanthine fork.
Editorial botanical source image for Kratom alkaloids.
Mitragynine and the corynanthe family

Kratom alkaloids

Mitragyna speciosa leaf chemistry is dominated by a few abundant alkaloids. Minor members are interesting and hard to access at scale.

Route corynanthe-type chemistry through fermentation instead of leaf extraction.
Editorial botanical source image for Ergolines.
Agroclavine and the broader ergoline alkaloid space

Ergolines

Ergot fungi run a slow, specialized program. Access to the ergoline scaffold has stayed narrow for a century.

Develop fermentation routes into agroclavine and the ergoline building blocks that feed future clinical NCEs.
Editorial botanical source image for Salvinorins.
The salvinorin scaffold and designed analogs

Salvinorins

Salvia divinorum chemistry is sparse in nature and structurally unusual. Wild leaf supply is limited.

Open repeatable access to salvinorin-family chemistry through engineered yeast.

Why supply matters.

Rare natural products can reveal important biology long before they are practical to access. Better routes turn scarce chemistry into material that can be compared, characterized, and expanded.

01

Reliable material

Consistent access makes it easier to compare rare natural products across studies and time.

02

Source resilience

Fermentation routes reduce dependence on slow, variable, or sensitive source chains.

03

Chemical reach

Better access makes neighboring natural-product and NCE space easier to evaluate.

Chemistry in view

Reference points and new space.

MIA pathway intermediate

Stemmadenine acetate

MIA pathway fork

Tabersonine

MIA pathway fork

Catharanthine

Kratom alkaloid reference point

Mitragynine

Salvinorin reference point

Salvinorins

R1R2R3
Future clinical NCE space

Designed analogs

MIA pathway intermediatesKratom alkaloidsErgolinesSalvinorinsFuture clinical NCEsDesigned analogsMIA pathway intermediatesKratom alkaloidsErgolinesSalvinorinsFuture clinical NCEsDesigned analogs